Cargando…

The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases

BACKGROUND: Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminths (STH) and trachoma represent the five most prevalent neglected tropical diseases (NTDs). They can be controlled or eliminated by means of safe and cost-effective interventions delivered through program...

Descripción completa

Detalles Bibliográficos
Autores principales: Redekop, William K., Lenk, Edeltraud J., Luyendijk, Marianne, Fitzpatrick, Christopher, Niessen, Louis, Stolk, Wilma A., Tediosi, Fabrizio, Rijnsburger, Adriana J., Bakker, Roel, Hontelez, Jan A. C., Richardus, Jan H., Jacobson, Julie, de Vlas, Sake J., Severens, Johan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313231/
https://www.ncbi.nlm.nih.gov/pubmed/28103243
http://dx.doi.org/10.1371/journal.pntd.0005289
_version_ 1782508325407031296
author Redekop, William K.
Lenk, Edeltraud J.
Luyendijk, Marianne
Fitzpatrick, Christopher
Niessen, Louis
Stolk, Wilma A.
Tediosi, Fabrizio
Rijnsburger, Adriana J.
Bakker, Roel
Hontelez, Jan A. C.
Richardus, Jan H.
Jacobson, Julie
de Vlas, Sake J.
Severens, Johan L.
author_facet Redekop, William K.
Lenk, Edeltraud J.
Luyendijk, Marianne
Fitzpatrick, Christopher
Niessen, Louis
Stolk, Wilma A.
Tediosi, Fabrizio
Rijnsburger, Adriana J.
Bakker, Roel
Hontelez, Jan A. C.
Richardus, Jan H.
Jacobson, Julie
de Vlas, Sake J.
Severens, Johan L.
author_sort Redekop, William K.
collection PubMed
description BACKGROUND: Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminths (STH) and trachoma represent the five most prevalent neglected tropical diseases (NTDs). They can be controlled or eliminated by means of safe and cost-effective interventions delivered through programs of Mass Drug Administration (MDA)—also named Preventive Chemotherapy (PCT). The WHO defined targets for NTD control/elimination by 2020, reinforced by the 2012 London Declaration, which, if achieved, would result in dramatic health gains. We estimated the potential economic benefit of achieving these targets, focusing specifically on productivity and out-of-pocket payments. METHODS: Productivity loss was calculated by combining disease frequency with productivity loss from the disease, from the perspective of affected individuals. Productivity gain was calculated by deducting the total loss expected in the target achievement scenario from the loss in a counterfactual scenario where it was assumed the pre-intervention situation in 1990 regarding NTDs would continue unabated until 2030. Economic benefits from out-of-pocket payments (OPPs) were calculated similarly. Benefits are reported in 2005 US$ (purchasing power parity-adjusted and discounted at 3% per annum from 2010). Sensitivity analyses were used to assess the influence of changes in input parameters. RESULTS: The economic benefit from productivity gain was estimated to be I$251 billion in 2011–2020 and I$313 billion in 2021–2030, considerably greater than the total OPPs averted of I$0.72 billion and I$0.96 billion in the same periods. The net benefit is expected to be US$ 27.4 and US$ 42.8 for every dollar invested during the same periods. Impact varies between NTDs and regions, since it is determined by disease prevalence and extent of disease-related productivity loss. CONCLUSION: Achieving the PCT-NTD targets for 2020 will yield significant economic benefits to affected individuals. Despite large uncertainty, these benefits far exceed the investment required by governments and their development partners within all reasonable scenarios. Given the concentration of the NTDs among the poorest households, these investments represent good value for money in efforts to share the world’s prosperity and reduce inequity.
format Online
Article
Text
id pubmed-5313231
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53132312017-03-03 The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases Redekop, William K. Lenk, Edeltraud J. Luyendijk, Marianne Fitzpatrick, Christopher Niessen, Louis Stolk, Wilma A. Tediosi, Fabrizio Rijnsburger, Adriana J. Bakker, Roel Hontelez, Jan A. C. Richardus, Jan H. Jacobson, Julie de Vlas, Sake J. Severens, Johan L. PLoS Negl Trop Dis Research Article BACKGROUND: Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminths (STH) and trachoma represent the five most prevalent neglected tropical diseases (NTDs). They can be controlled or eliminated by means of safe and cost-effective interventions delivered through programs of Mass Drug Administration (MDA)—also named Preventive Chemotherapy (PCT). The WHO defined targets for NTD control/elimination by 2020, reinforced by the 2012 London Declaration, which, if achieved, would result in dramatic health gains. We estimated the potential economic benefit of achieving these targets, focusing specifically on productivity and out-of-pocket payments. METHODS: Productivity loss was calculated by combining disease frequency with productivity loss from the disease, from the perspective of affected individuals. Productivity gain was calculated by deducting the total loss expected in the target achievement scenario from the loss in a counterfactual scenario where it was assumed the pre-intervention situation in 1990 regarding NTDs would continue unabated until 2030. Economic benefits from out-of-pocket payments (OPPs) were calculated similarly. Benefits are reported in 2005 US$ (purchasing power parity-adjusted and discounted at 3% per annum from 2010). Sensitivity analyses were used to assess the influence of changes in input parameters. RESULTS: The economic benefit from productivity gain was estimated to be I$251 billion in 2011–2020 and I$313 billion in 2021–2030, considerably greater than the total OPPs averted of I$0.72 billion and I$0.96 billion in the same periods. The net benefit is expected to be US$ 27.4 and US$ 42.8 for every dollar invested during the same periods. Impact varies between NTDs and regions, since it is determined by disease prevalence and extent of disease-related productivity loss. CONCLUSION: Achieving the PCT-NTD targets for 2020 will yield significant economic benefits to affected individuals. Despite large uncertainty, these benefits far exceed the investment required by governments and their development partners within all reasonable scenarios. Given the concentration of the NTDs among the poorest households, these investments represent good value for money in efforts to share the world’s prosperity and reduce inequity. Public Library of Science 2017-01-19 /pmc/articles/PMC5313231/ /pubmed/28103243 http://dx.doi.org/10.1371/journal.pntd.0005289 Text en © 2017 Redekop et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Redekop, William K.
Lenk, Edeltraud J.
Luyendijk, Marianne
Fitzpatrick, Christopher
Niessen, Louis
Stolk, Wilma A.
Tediosi, Fabrizio
Rijnsburger, Adriana J.
Bakker, Roel
Hontelez, Jan A. C.
Richardus, Jan H.
Jacobson, Julie
de Vlas, Sake J.
Severens, Johan L.
The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
title The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
title_full The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
title_fullStr The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
title_full_unstemmed The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
title_short The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
title_sort socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313231/
https://www.ncbi.nlm.nih.gov/pubmed/28103243
http://dx.doi.org/10.1371/journal.pntd.0005289
work_keys_str_mv AT redekopwilliamk thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT lenkedeltraudj thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT luyendijkmarianne thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT fitzpatrickchristopher thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT niessenlouis thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT stolkwilmaa thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT tediosifabrizio thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT rijnsburgeradrianaj thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT bakkerroel thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT hontelezjanac thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT richardusjanh thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT jacobsonjulie thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT devlassakej thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT severensjohanl thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT redekopwilliamk socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT lenkedeltraudj socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT luyendijkmarianne socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT fitzpatrickchristopher socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT niessenlouis socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT stolkwilmaa socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT tediosifabrizio socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT rijnsburgeradrianaj socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT bakkerroel socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT hontelezjanac socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT richardusjanh socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT jacobsonjulie socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT devlassakej socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases
AT severensjohanl socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases